Skip to content

Dolby Laboratories, Inc. DLB Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

Lattice Semiconductor logo
Lattice SemiconductorLSCC
$1.87M-2.2%

Other financials

Income statement

See full
Revenue$395.6M+7.1%
Gross profit$350.9M+5.1%
Operating income$112.9M+4.8%
Net income$94.9M+3.4%
EPS (diluted)$0.99+5.3%

Balance sheet

See full
Cash & equivalents$673.8M-10.2%
Total debt$49.7M+22.9%
Total equity$2.6B+1.7%
Total assets$3.2B+0.6%

Cash flow

See full
Operating cash flow$92.5M-47.1%
CapEx$9.1M+31.4%
Free cash flow$83.4M-50.3%

Valuation

See full
Market cap$4.95B-25.9%

Profitability

See full
Gross margin87.4%-1.5pp
Operating margin18.5%-2.0pp
Net margin17.9%-1.6pp
FCF margin22.1%-7.5pp

Returns & leverage

See full
Return on equity9.4%-0.9pp
Debt / equity0.0×
Current ratio-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dolby Laboratories, Inc.'s non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dolby Laboratories, Inc.'s non-cash lease expense?
Dolby Laboratories, Inc. (DLB) reported non-cash lease expense of $2.75M in Q1 2026.
How has Dolby Laboratories, Inc.'s non-cash lease expense changed year-over-year?
Dolby Laboratories, Inc.'s non-cash lease expense decreased by 4.9% year-over-year, from $2.89M to $2.75M.
What is the long-term trend for Dolby Laboratories, Inc.'s non-cash lease expense?
Over 4 years (2021 to 2025), Dolby Laboratories, Inc.'s non-cash lease expense has grown at a -10.6% compound annual growth rate (CAGR), from $16.9M to $10.77M.
What does non-cash lease expense mean?
Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.